Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2019
Price and Ordering Information
Subscription Rates 2019
Subscription Rates 2018
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
eBooks Website
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Bentham Online
Accessibility Of Content
Bentham Insight
Online Feedback
Purchase Articles
Search Articles
Social Media
Submit Manuscripts
Marketing Opportunities
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2019
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Kudos
Media Partners
Partnering Events
Promotional Services
For Librarians
FAQ’s for e-prints/reprints
Journal Catalog 2018
Library Recommendations
Order Bulk ePrints
Order Bulk Reprints
Table of Contents Alert
Trial Requests
For Authors & Editors
Author Benefits
Author Reprints
Author's Benefits Guide
Copyediting Services
Editorial Policies
General FAQs
Guidelines for Guest Editors
Manuscript Transfer Facility
Online Manuscript Submission
Journal Catalog 2018
Publication Cycle - Process Flowchart
Publishing Ethics
Reviewer Guidelines
Self-Archiving Policies
Table of Contents Alert
More
About Us
Contact
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
Volume 19, 11 Issues, 2019
Download PDF Flyer
Current Cancer Drug Targets
This journal supports open access
Impact Factor:
2.626
5 - Year Impact Factor:
3.186
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Advertise With Us
Library Recommendation
Trial Requests
Special Issue Submission
Thematic Issues
Open Access Funding
More Options
Manuscript Transfer Facility
Advertisement
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
Volume 19, 11 Issues, 2019
Download PDF Flyer
Current Cancer Drug Targets
This journal supports open access
Impact Factor:
2.626
5 - Year Impact Factor:
3.186
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Advertise With Us
Library Recommendation
Trial Requests
Special Issue Submission
Thematic Issues
Open Access Funding
More Options
Manuscript Transfer Facility
Current Cancer Drug Targets
This journal supports open access
Quick Links
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Advertise With Us
Library Recommendation
Trial Requests
Special Issue Submission
Thematic Issues
Open Access Funding
Manuscript Transfer Facility
Impact Factor:
2.626
5 - Year Impact Factor:
3.186
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
More Options
Submit Manuscripts Online
Editor-in-Chief:
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Subscribe
More Options
Purchase Articles
Order Reprints
Contents
Current Cancer Drug Targets
,
Volume 17
- Number 4
Biography
Meet Our Editorial Board Member
,
17
(
4
):
303
Thomas W. Grunt
DOI:
10.2174/156800961704170419204900
View Biography
Download Free
Review Article
Synthetic Lethal Interactions in Cancer Therapy
,
17
(
4
):
304
- 310
Xinwei Geng, Xiaohui Wang, Dan Zhu and Songmin Ying
DOI:
10.2174/1568009616666160426122736
×
Synthetic Lethal Interactions in Cancer Therapy
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Chemotherapy and Cardiotoxicity in Hematologic Malignancies
,
17
(
4
):
311
- 324
Antonio Stellitano, Roberta Fedele, Santina Barilla, Antonino Iaria, Carmelo Massimiliano Rao and Massimo Martino
DOI:
10.2174/1568009617666161121141607
×
Chemotherapy and Cardiotoxicity in Hematologic Malignancies
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
,
17
(
4
):
325
- 332
Vladimir Stanislavovich Rogovskii
DOI:
10.2174/1568009617666170109110816
×
The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias
,
17
(
4
):
333
- 343
Weronika Bereza, Joanna Szczepanek, Joanna Laskowska and Andrzej Tretyn
DOI:
10.2174/1568009616666161208150148
×
New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
,
17
(
4
):
344
- 356
Heena Singla, Sourav Kalra, Preeti Kheterpal, Vinod Kumar and Anjana Munshi
DOI:
10.2174/1568009616666161216094026
×
Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
,
17
(
4
):
357
- 375
Bhupinder Kumar, Rakesh Kumar, Ira Skvortsova and Vinod Kumar
DOI:
10.2174/1568009616666160928110818
×
Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway
,
17
(
4
):
376
- 385
Ruzhen Zheng, Hao Jiang, Jinhui Li, Xinge Liu and Hongwei Xu
DOI:
10.2174/1568009616666161213141608
×
Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
,
17
(
4
):
386
- 401
Qiaohua Zhu, Xinfa Yu, Zhi-Wei Zhou, Chengyu Zhou, Xiao-Wu Chen and Shu-Feng Zhou
DOI:
10.2174/1568009616666160630182344
×
Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Webmaster Contact:
info@benthamscience.net
Copyright © 2019 Bentham Science